Intec offers potential partners a rapid and cost effective human proof-of-concept (POC), to demonstrate the superiority of their specific drugs when administered with a designated Accordion Pill™, in comparison to the current, marketed version of these drugs.

Formulation Development
Scale-up & Production
Batch Release
Human POC
Activity Development of designated Accordion Pill  with partner’s drug, with a desired  release profile Scale up & production for human POC, in Intec’s cGMP pilot production sites POC study stability and QC/QA batch release PK human study: AP drug vs. the existing, marketed drug, in healthy volunteers
Outcome dissolution profile Bio batch for human POC COA, Stability report PK profiles
Typical Duration, Month 3-4 2 1 3, including Bioanalysis 9-10